Therapy Clinical Trials in Beijing
28 recruitingBeijing, China
Showing 1–20 of 28 trials
Recruiting
Phase 2
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Salivary Gland CarcinomaPrecision Therapy
Peking Union Medical College39 enrolled2 locationsNCT06145308
Recruiting
Phase 2
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca257 enrolled59 locationsNCT06535607
Recruiting
Phase 3
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Esophagus CancerChemotherapy EffectTargeted Therapy+3 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2,000 enrolled5 locationsNCT04821778
Recruiting
Phase 3
Neoadjuvant Treatment Modalities in Esophageal Cancer
Esophageal CancerSurgeryChemotherapy Effect+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2,000 enrolled1 locationNCT04821843
Recruiting
Phase 3
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Radiotherapy, AdjuvantHepatocellular Carcinoma (HCC)Immune Checkpoint Inhibitor+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences286 enrolled1 locationNCT07186621
Recruiting
Not Applicable
Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
Colon CancerImmunotherapyMismatch Repair Deficiency
Peking Union Medical College Hospital18 enrolled2 locationsNCT06215677
Recruiting
Phase 4
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University800 enrolled8 locationsNCT06195228
Recruiting
Phase 3
GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Qilu Pharmaceutical Co., Ltd.352 enrolled1 locationNCT06994507
Recruiting
Phase 2
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)Adjuvant ChemoradiotherapyNarrow Margin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences66 enrolled1 locationNCT07063888
Recruiting
Phase 2
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Esophageal CancerSurgeryImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled3 locationsNCT06421376
Recruiting
Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy
Immunotherapy
jianming xu50 enrolled1 locationNCT06946745
Recruiting
Phase 3
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Cervical CancerAdaptive Radiotherapy
Peking Union Medical College Hospital440 enrolled1 locationNCT06641635
Recruiting
Phase 1Phase 2
Chemoradiotherapy in Unresectable Esophageal Cancer
Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences105 enrolled5 locationsNCT04278287
Recruiting
Phase 2
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients
Non-small Cell Lung CancerConsolidation ImmunotherapyRadiotherapy or Sequential Chemoradiation
Peking University Cancer Hospital & Institute20 enrolled1 locationNCT05758116
Recruiting
Phase 2
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
Esophageal CancerChemotherapyImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences55 enrolled1 locationNCT06429839
Recruiting
Phase 2
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
Esophageal CancerChemotherapyImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences53 enrolled1 locationNCT06410651
Recruiting
Phase 2
Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Hepatocellular CarcinomaRadiotherapyNarrow Margin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences100 enrolled1 locationNCT06205472
Recruiting
Not Applicable
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
Lung CancerChemotherapyImmune Checkpoint Inhibitor+3 more
Peking Union Medical College Hospital1,224 enrolled1 locationNCT06168032
Recruiting
Comparison of Efficacy in SBRT of Large HCC With or Without TACE
Stereotactic Body Radiation TherapyTranscatheter Arterial ChemoembolizationLarge HCC Patients
Beijing 302 Hospital100 enrolled1 locationNCT04512846
Recruiting
Phase 2
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
Breast CancerRadiotherapy Side Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences65 enrolled1 locationNCT05762900